Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

11.92
Delayed Data
As of Apr 28
 -0.3928 / -3.19%
Today’s Change
3.50
Today|||52-Week Range
12.50
+122.75%
Year-to-Date

Today’s Trading

Previous close12.31
Today’s open12.21
Day’s range11.74 - 12.21
Volume21,682
Average volume (3 months)27,722
Market cap$949.1M
Dividend yield--
Data as of 3:59pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-1,210.67%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
ITGRInteger Holdings Cor...-0.05-0.14%
OFIXOrthofix Internation...-0.27-0.68%
IVCInvacare Corp+1.45+10.94%
CFMSConforMIS Inc0.000.00%
Data as of 4:02pm ET, 04/28/2017

Financials

Next reporting dateMay 8, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts